{"id":{"repo_id":"greece","oai_identifier":"oai:10442/0405"},"canonical_url":"https://search.dev.ndltd.org/etd/greece/oai:10442/0405","repository":{"repo_id":"greece","name":"Greek National Archive of PhD Theses","base_url":"https://phdtheses.ekt.gr/eadd_oai/request"},"display":{"title":"ΣΥΣΤΗΜΑ ΙΣΤΟΣΥΜΒΑΤΟΤΗΤΟΣ H L A ΚΑΙ ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟΣ ΤΟΥ ΜΑΣΤΟΥ","abstract":"ONE HUNDRED AND TEN PATIENTS WITH FIBROCYSTIS DISEASE OF THE BREAST AND 200 CONTROLS WERE HLA TYPED WITH A PANEL OF 100 ANTISERA FOR A AND B LOCUS. THE MAIN FINDINGS WERE AN INCREASE IN FREQUENCY OF A 11 ANTIGEN AND A DECREASE IN FREQUENCY OF BW 35 ANTIGEN AMONG THE PATIENTS COMPARED WITH THE CONTROL GROUP. THE DIFFERENCE IN FREQUENCY OF A 11 ANTIGEN WAS MORE SIGNIFICANT IN PATIENTS WITH THE FIBROCYSTIC TYPE OF DISEASE AND ALSO IN PATIENTS WITH A FAMILY HISTORY OF BREAST CANCER. CHILD-BEARING SEEMS TO EXERT A BENEFICIAL EFFECT UPON THE APPEARANCE OF BOTH TYPES OF BREAST DISEASES.","abstract_html":"ONE HUNDRED AND TEN PATIENTS WITH FIBROCYSTIS DISEASE OF THE BREAST AND 200 CONTROLS WERE HLA TYPED WITH A PANEL OF 100 ANTISERA FOR A AND B LOCUS. THE MAIN FINDINGS WERE AN INCREASE IN FREQUENCY OF A 11 ANTIGEN AND A DECREASE IN FREQUENCY OF BW 35 ANTIGEN AMONG THE PATIENTS COMPARED WITH THE CONTROL GROUP. THE DIFFERENCE IN FREQUENCY OF A 11 ANTIGEN WAS MORE SIGNIFICANT IN PATIENTS WITH THE FIBROCYSTIC TYPE OF DISEASE AND ALSO IN PATIENTS WITH A FAMILY HISTORY OF BREAST CANCER. CHILD-BEARING SEEMS TO EXERT A BENEFICIAL EFFECT UPON THE APPEARANCE OF BOTH TYPES OF BREAST DISEASES.","abstract_has_math":false,"creators":["Σούλλερ-Πανάγου, Μελπομένη"],"institution":"National and Kapodistrian University of Athens","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":1985,"date_issued":"1985","date_published":"1985","updated_at":"2026-07-24T02:25:14Z","subjects":["H L A - ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟΣ","Fibrocystic disease of the breast","H L A A - H L A B LOCUS","Ιατρική και Επιστήμες Υγείας","Κλινική Ιατρική","Medical and Health Sciences","Clinical Medicine"],"languages":["gre"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/0405"],"render_values":[{"text":"10.12681/eadd/0405","href":"https://doi.org/10.12681/eadd/0405","code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/10442/hedi/0405","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Σούλλερ-Πανάγου, Μελπομένη"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["1985"]},{"key":"dc:publisher","label":"Institution","values":["National and Kapodistrian University of Athens","Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)"]},{"key":"dc:type","label":"Dc Type","values":["PhD Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["H L A - ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟΣ","Fibrocystic disease of the breast","H L A A - H L A B LOCUS","Ιατρική και Επιστήμες Υγείας","Κλινική Ιατρική","Medical and Health Sciences","Clinical Medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["gre"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/0405","http://hdl.handle.net/10442/hedi/0405"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["ONE HUNDRED AND TEN PATIENTS WITH FIBROCYSTIS DISEASE OF THE BREAST AND 200 CONTROLS WERE HLA TYPED WITH A PANEL OF 100 ANTISERA FOR A AND B LOCUS. THE MAIN FINDINGS WERE AN INCREASE IN FREQUENCY OF A 11 ANTIGEN AND A DECREASE IN FREQUENCY OF BW 35 ANTIGEN AMONG THE PATIENTS COMPARED WITH THE CONTROL GROUP. THE DIFFERENCE IN FREQUENCY OF A 11 ANTIGEN WAS MORE SIGNIFICANT IN PATIENTS WITH THE FIBROCYSTIC TYPE OF DISEASE AND ALSO IN PATIENTS WITH A FAMILY HISTORY OF BREAST CANCER. CHILD-BEARING SEEMS TO EXERT A BENEFICIAL EFFECT UPON THE APPEARANCE OF BOTH TYPES OF BREAST DISEASES.","ΣΤΗΝ ΕΡΓΑΣΙΑ ΑΥΤΗ ΜΕΛΕΤΗΘΗΚΕ Η ΣΥΧΝΟΤΗΤΑ 29 HLA ΑΝΤΙΓΟΝΩΝ ΣΕ 110 ΑΣΘΕΝΕΙΣ ΜΕ ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟ ΤΟΥ ΜΑΣΤΟΥ ΚΑΙ 200 ΥΓΙΕΙΣ ΜΑΡΤΥΡΕΣ. Η ΤΥΠΟΠΟΙΗΣΗ ΤΩΝ ΑΝΤΙΓΟΝΩΝ HLA-A ΚΑΙ HLA-B, ΕΓΙΝΕ ΜΕ ΤΗ ΛΕΜΦΟΚΥΤΤΑΡΟΤΟΞΙΚΗ ΔΟΚΙΜΑΣΙΑ TERASAKI. ΣΚΟΠΟΣ ΤΗΣ ΕΡΓΑΣΙΑΣ ΗΤΑΝ Η ΑΝΑΖΗΤΗΣΗ ΣΧΕΣΕΩΝ HLA ΑΝΤΙΓΟΝΩΝ ΜΕ ΤΗΝ ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟ ΤΟΥ ΜΑΣΤΟΥΓΙΑ ΠΙΘΑΝΗ ΥΠΑΡΞΗ ΓΕΝΕΤΙΚΗΣ ΕΥΠΑΘΕΙΑΣ ΣΤΗΝ ΕΚΔΗΛΩΣΗ ΤΗΣ ΝΟΣΟΥ. ΔΙΑΠΙΣΤΩΘΗΚΕ ΑΥΞΗΣΗ ΤΗΣ ΣΥΧΝΟΤΗΤΑΣ ΤΟΥ A 11 ΑΝΤΙΓΟΝΟΥ ΚΑΙ ΕΛΑΤΤΩΣΗ ΤΗΣ ΣΥΧΝΟΤΗΤΑΣ ΤΟΥ BW 35 ΜΕΤΑΞΥ ΤΩΝ ΑΣΘΕΝΩΝ ΣΕ ΣΥΓΚΡΙΣΗ ΜΕ ΤΟΥΣ ΜΑΡΤΥΡΕΣ. Η ΑΥΞΗΣΗ ΤΟΥ Α 11 ΑΝΤΙΓΟΝΟΥ ΠΑΡΕΜΕΙΝΕ ΣΗΜΑΝΤΙΚΗ ΣΤΗΝ ΥΠΟΟΜΑΔΑ ΤΩΝ ΑΣΘΕΝΩΝ ΜΕ ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟ, ΕΝΩ Η ΜΕΙΩΣΗ ΤΟΥBW 35 ΠΑΡΕΜΕΙΝΕ ΣΗΜΑΝΤΙΚΗ ΣΤΗΝ ΥΠΟΟΜΑΔΑ ΤΩΝ ΑΣΘΕΝΩΝ ΜΕ ΙΝΩΔΗ ΝΟΣΟ, ΚΑΘΩΣ ΚΑΙ ΣΤΟΥΣ ΑΣΘΕΝΕΙΣ ΜΕ ΟΙΚΟΝΓΕΝΕΙΑΚΟ ΙΣΤΟΡΙΚΟ ΚΑΡΚΙΝΟΥ ΤΟΥ ΜΑΣΤΟΥ. Η ΤΕΚΝΟΠΟΙΗΣΗ ΤΕΛΟΣ ΦΑΙΝΕΤΑΙ ΝΑ ΕΠΙΔΡΑ ΕΥΕΡΓΕΤΙΚΑ ΚΑΙ ΣΤΙΣ ΔΥΟ ΥΠΟΟΜΑΔΕΣ ΤΩΝ ΑΣΘΕΝΩΝ."]},{"key":"dc:title","label":"Title","values":["ΣΥΣΤΗΜΑ ΙΣΤΟΣΥΜΒΑΤΟΤΗΤΟΣ H L A ΚΑΙ ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟΣ ΤΟΥ ΜΑΣΤΟΥ","H L A ANTIGENS AND FIBROCYSTIS DISEASE"]}]}],"canonical_facts":{"dc:creator":["Σούλλερ-Πανάγου, Μελπομένη"],"dc:date":["1985"],"dc:description":["ONE HUNDRED AND TEN PATIENTS WITH FIBROCYSTIS DISEASE OF THE BREAST AND 200 CONTROLS WERE HLA TYPED WITH A PANEL OF 100 ANTISERA FOR A AND B LOCUS. THE MAIN FINDINGS WERE AN INCREASE IN FREQUENCY OF A 11 ANTIGEN AND A DECREASE IN FREQUENCY OF BW 35 ANTIGEN AMONG THE PATIENTS COMPARED WITH THE CONTROL GROUP. THE DIFFERENCE IN FREQUENCY OF A 11 ANTIGEN WAS MORE SIGNIFICANT IN PATIENTS WITH THE FIBROCYSTIC TYPE OF DISEASE AND ALSO IN PATIENTS WITH A FAMILY HISTORY OF BREAST CANCER. CHILD-BEARING SEEMS TO EXERT A BENEFICIAL EFFECT UPON THE APPEARANCE OF BOTH TYPES OF BREAST DISEASES.","ΣΤΗΝ ΕΡΓΑΣΙΑ ΑΥΤΗ ΜΕΛΕΤΗΘΗΚΕ Η ΣΥΧΝΟΤΗΤΑ 29 HLA ΑΝΤΙΓΟΝΩΝ ΣΕ 110 ΑΣΘΕΝΕΙΣ ΜΕ ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟ ΤΟΥ ΜΑΣΤΟΥ ΚΑΙ 200 ΥΓΙΕΙΣ ΜΑΡΤΥΡΕΣ. Η ΤΥΠΟΠΟΙΗΣΗ ΤΩΝ ΑΝΤΙΓΟΝΩΝ HLA-A ΚΑΙ HLA-B, ΕΓΙΝΕ ΜΕ ΤΗ ΛΕΜΦΟΚΥΤΤΑΡΟΤΟΞΙΚΗ ΔΟΚΙΜΑΣΙΑ TERASAKI. ΣΚΟΠΟΣ ΤΗΣ ΕΡΓΑΣΙΑΣ ΗΤΑΝ Η ΑΝΑΖΗΤΗΣΗ ΣΧΕΣΕΩΝ HLA ΑΝΤΙΓΟΝΩΝ ΜΕ ΤΗΝ ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟ ΤΟΥ ΜΑΣΤΟΥΓΙΑ ΠΙΘΑΝΗ ΥΠΑΡΞΗ ΓΕΝΕΤΙΚΗΣ ΕΥΠΑΘΕΙΑΣ ΣΤΗΝ ΕΚΔΗΛΩΣΗ ΤΗΣ ΝΟΣΟΥ. ΔΙΑΠΙΣΤΩΘΗΚΕ ΑΥΞΗΣΗ ΤΗΣ ΣΥΧΝΟΤΗΤΑΣ ΤΟΥ A 11 ΑΝΤΙΓΟΝΟΥ ΚΑΙ ΕΛΑΤΤΩΣΗ ΤΗΣ ΣΥΧΝΟΤΗΤΑΣ ΤΟΥ BW 35 ΜΕΤΑΞΥ ΤΩΝ ΑΣΘΕΝΩΝ ΣΕ ΣΥΓΚΡΙΣΗ ΜΕ ΤΟΥΣ ΜΑΡΤΥΡΕΣ. Η ΑΥΞΗΣΗ ΤΟΥ Α 11 ΑΝΤΙΓΟΝΟΥ ΠΑΡΕΜΕΙΝΕ ΣΗΜΑΝΤΙΚΗ ΣΤΗΝ ΥΠΟΟΜΑΔΑ ΤΩΝ ΑΣΘΕΝΩΝ ΜΕ ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟ, ΕΝΩ Η ΜΕΙΩΣΗ ΤΟΥBW 35 ΠΑΡΕΜΕΙΝΕ ΣΗΜΑΝΤΙΚΗ ΣΤΗΝ ΥΠΟΟΜΑΔΑ ΤΩΝ ΑΣΘΕΝΩΝ ΜΕ ΙΝΩΔΗ ΝΟΣΟ, ΚΑΘΩΣ ΚΑΙ ΣΤΟΥΣ ΑΣΘΕΝΕΙΣ ΜΕ ΟΙΚΟΝΓΕΝΕΙΑΚΟ ΙΣΤΟΡΙΚΟ ΚΑΡΚΙΝΟΥ ΤΟΥ ΜΑΣΤΟΥ. Η ΤΕΚΝΟΠΟΙΗΣΗ ΤΕΛΟΣ ΦΑΙΝΕΤΑΙ ΝΑ ΕΠΙΔΡΑ ΕΥΕΡΓΕΤΙΚΑ ΚΑΙ ΣΤΙΣ ΔΥΟ ΥΠΟΟΜΑΔΕΣ ΤΩΝ ΑΣΘΕΝΩΝ."],"dc:identifier":["10.12681/eadd/0405","http://hdl.handle.net/10442/hedi/0405"],"dc:language":["gre"],"dc:publisher":["National and Kapodistrian University of Athens","Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)"],"dc:subject":["H L A - ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟΣ","Fibrocystic disease of the breast","H L A A - H L A B LOCUS","Ιατρική και Επιστήμες Υγείας","Κλινική Ιατρική","Medical and Health Sciences","Clinical Medicine"],"dc:title":["ΣΥΣΤΗΜΑ ΙΣΤΟΣΥΜΒΑΤΟΤΗΤΟΣ H L A ΚΑΙ ΙΝΟΚΥΣΤΙΚΗ ΝΟΣΟΣ ΤΟΥ ΜΑΣΤΟΥ","H L A ANTIGENS AND FIBROCYSTIS DISEASE"],"dc:type":["PhD Thesis"]},"updated_at":"2026-07-24T02:25:14Z"}